In this podcast, Motley Fool analysts Asit Sharma, Ron Gross, and Matt Argersinger talk about:
Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks
McKesson (MCK): Buy, Sell, or Hold Post Q4 Earnings?
/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
As Cencora has outperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.
/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
As McKesson has outperformed the Dow Jones over the past year, analysts are bullish about the stock’s prospects.
Owens & Minor (OMI) Reports Q4: Everything You Need To Know Ahead Of Earnings
Take a gander at these three stocks that are generating returns on invested capital (ROIC) that are among the best in the U.S. large-cap stock universe.
McKesson has underperformed relative to the S&P 500 Index over the past year, but Wall Street analysts remain bullish on its growth prospects.
Brookdale (BKD) Reports Earnings Tomorrow: What To Expect